Sitagliptin (JANUVIA tab) is indicated to improve glucose control in adults with type 2 diabetes mellitus along with diet and exercise. The information provided on this page is intended to serve as a ...
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- In a new post-hoc analysis presented for the first time at the American Diabetes Association (ADA) 70 th Annual Scientific Sessions, significantly more ...
WHITEHOUSE STATION, N.J. -- Merck & Co., Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved expanded labeling for JANUVIA(TM) (sitagliptin), the only DPP-4 inhibitor ...
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the primary results of the Trial Evaluating Cardiovascular Outcomes with ...
The primary endpoint of the study was to assess if the change from baseline in HbA1c achieved with ONGLYZA 5 mg per day was non-inferior (defined in the study protocol as a treatment group numerical ...
Zydus Cadila a leading Indian pharmaceutical company announced that its subsidiary has received tentative approval from the United States Food and Drug Administration (FDA) for its new drug ...
The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Sitagliptin (JANUVIA tab) is indicated to improve ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback